Evidence map›Paper›PMID 34449404›Full record

ArticleJMIR formative research2021

The Use of Telemonitoring in Managing the COVID-19 Pandemic: Pilot Implementation Study.

Brian McKinstry, Helen Alexander, Gabriela Maxwell, Lesley Blaikie, Sameer Patel, Bruce Guthrie, Technology Enabled Care TeleCOVID Group

Open access · goldAbstract read
In one paragraph

Article in JMIR formative research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Brian McKinstryCentre for Informatics, Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0001-9581-0468
Helen AlexanderPlanning & Development, NHS Lanarkshire, Bothwell, United Kingdom.ORCID https://orcid.org/0000-0001-8310-5067
Gabriela MaxwellPrimary Care Nursing, South Lanarkshire Health and Social Care Partnership, NHS Lanarkshire, Hamilton, United Kingdom.ORCID https://orcid.org/0000-0003-4634-7985
Lesley BlaikieCystic Fibrosis Service, NHS Highland, Inverness, United Kingdom.ORCID https://orcid.org/0000-0002-6236-1093
Sameer Patel *NHS Education for Scotland Technology, Glasgow, United Kingdom.ORCID https://orcid.org/0000-0002-0492-2163
Bruce GuthrieCollege of Medicine & Veterinary Medicine, Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0003-4191-4880
Technology Enabled Care TeleCOVID Group *See Acknowledgments, Edinburgh, United Kingdom.
NHS Lanarkshire · GBEdinburgh College · GBKnowledge Centre for Agriculture · DKNHS Education for Scotland · GBNHS Highland · GBUniversity of Edinburgh · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMost people with COVID-19 self-manage at home. However, the condition can deteriorate quickly, and some people may develop serious hypoxia with relatively few symptoms. Early identification of deterioration allows effective management with oxygen and steroids. Telemonitoring of symptoms and physiological signs may facilitate this.

objectiveThe aim of this study was to design, implement, and evaluate a telemonitoring system for people with COVID-19 who are self-managing at home and are considered at significant risk of deterioration.

methodsA multidisciplinary team developed a telemonitoring protocol using a commercial platform to record symptoms, pulse oximetry, and temperature. If symptoms or physiological measures breached targets, patients were alerted and asked to phone for an ambulance (red alert) or for advice (amber alert). Patients attending COVID-19 assessment centers, who were considered fit for discharge but at risk of deterioration, were shown how to use a pulse oximeter and the monitoring system, which they were to use twice daily for 2 weeks. Patients could interact with the system via app, SMS, or touch-tone phone. Written guidance on alerts was also provided. Following consent, patient data on telemonitoring usage and alerts were linked to data on the use of service resources. Subsequently, patients who had either used or not used the telemonitoring service, including those who had not followed advice to seek help, agreed to brief telephone interviews to explore their views on, and how they had interacted with, the telemonitoring system. Interviews were recorded and analyzed thematically. Professionals involved in the implementation were sent an online questionnaire asking them about their perceptions of the service.

resultsWe investigated the first 116 patients who used the service. Of these patients, 71 (61.2%) submitted data and the remainder (n=45, 38.8%) chose to self-monitor without electronic support. Of the 71 patients who submitted data, 35 (49%) received 152 alerts during their 2-week observation. A total of 67 red alerts were for oxygen saturation (SpO

conclusionsSupported self-monitoring of patients with COVID-19 at home is reassuring to patients, is acceptable to clinicians, and can detect important signs of deterioration. Worryingly, some patients, because they felt well, occasionally ignored important signs of deterioration. It is important, therefore, to emphasize the importance of the early investigation and treatment of asymptomatic hypoxia at the time when patients are initiated and in the warning messages that are sent to patients.

Indexed as

COVID-19eHealthprimary caretelemonitoring

Identifiers

PMID34449404
PMCPMC8477907
OpenAlexW3194038656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.